The chemical class known as KBTBD11 Inhibitors encompasses a range of compounds designed to modulate the activity of the Kelch Repeat and BTB (POZ) Domain Containing 11 protein. These inhibitors are primarily characterized by their ability to interfere with the functional mechanisms of KBTBD11, which may include disrupting its protein-protein interactions, hindering its role in ubiquitination processes, or altering its regulatory pathways. The diversity of these compounds reflects the complex nature of targeting a protein that is involved in multiple cellular functions, including protein degradation, signaling, and possibly gene expression regulation. The inhibitors might act by directly binding to KBTBD11, thereby blocking its interaction with other proteins, or they might influence the upstream signaling pathways or post-translational modifications that control the activity or stability of KBTBD11.
Given the involvement of KBTBD11 in various cellular processes, the impact of inhibiting this protein can be significant and widespread. By modulating the activity of KBTBD11, these inhibitors can alter the ubiquitination and degradation of key regulatory proteins, thereby affecting cellular homeostasis, response to stress, and other critical cellular functions. The specific effects of these inhibitors depend on the nature of their interaction with KBTBD11 and the cellular context in which they are used. The development and study of KBTBD11 inhibitors require an understanding of the protein's structure, the dynamics of its interactions, and the cellular pathways in which it is involved. Researchers aim to identify inhibitors with high specificity and potency, minimizing off-target effects and maximizing the desired modulation of KBTBD11 activity. As our understanding of KBTBD11 and its role in cellular physiology expands, so too will the sophistication and efficacy of the inhibitors designed to modulate its activity, offering potential insights into protein regulation, signaling, and the complex interplay of cellular mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Could possibly inhibit KBTBD11 by preventing the degradation of its substrates or regulatory proteins via proteasome inhibition. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
Could possibly inhibit KBTBD11 by affecting cullin-RING ligase activity, as some BTB domain proteins are part of these complexes, via NEDD8-activating enzyme inhibition. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Could possibly inhibit KBTBD11 by reducing the degradation of proteins regulated by it, thus affecting its functional pathways via proteasome inhibition. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Could possibly inhibit KBTBD11 by affecting the turnover of proteins regulated by it, altering its pathway activities via proteasome inhibition. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Could possibly inhibit KBTBD11 by disrupting the ubiquitination process via inhibition of ubiquitin-activating enzyme E1. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Could possibly inhibit KBTBD11 by inhibiting the degradation of its substrates, impacting its function via specific proteasome inhibition. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Could possibly inhibit KBTBD11 by inhibiting proteasomal activity, possibly affecting KBTBD11-mediated protein degradation. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Could possibly inhibit KBTBD11 by altering proteasomal degradation pathways, impacting its function via selective proteasome inhibition. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Could possibly inhibit KBTBD11 through multiple pathways, including inhibition of protein interactions or signaling pathways, given its broad biological effects. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Could possibly inhibit KBTBD11 by affecting proteasomal activity, possibly influencing KBTBD11 activity or its substrates via triterpenoid action. |